319 related articles for article (PubMed ID: 11112479)
1. The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.
Martín J; Ferguson GL; Wood DJ; Minor PD
Virology; 2000 Dec; 278(1):42-9. PubMed ID: 11112479
[TBL] [Abstract][Full Text] [Related]
2. Risks of reintroduction of polio after eradication: the vaccine origin of an outbreak of type 3 poliomyelitis.
Martin J; Ferguson GL; Wood DJ; Minor PD
Dev Biol (Basel); 2001; 105():83-92. PubMed ID: 11763341
[TBL] [Abstract][Full Text] [Related]
3. WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland.
Melnick JL; Berencsi G; Biberi-Moroeanu S; Combiescu AA; Furesz J; Kantoch M; Kostrzewski J; Magrath DI; Perkins FT; Vonka V; Cockburn WC; Dömök I; Assaad FA
Bull World Health Organ; 1972; 47(3):287-94. PubMed ID: 4346582
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
Minor P
Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
[TBL] [Abstract][Full Text] [Related]
5. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
Macadam AJ; Ferguson G; Stone DM; Meredith J; Knowlson S; Auda G; Almond JW; Minor PD
J Virol; 2006 Sep; 80(17):8653-63. PubMed ID: 16912313
[TBL] [Abstract][Full Text] [Related]
6. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
Friedrich F
Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola.
Vinjé J; Gregoricus N; Martin J; Gary HE; Caceres VM; Venczel L; Macadam A; Dobbins JG; Burns C; Wait D; Ko G; Landaverde M; Kew O; Sobsey MD
J Infect Dis; 2004 Apr; 189(7):1168-75. PubMed ID: 15031784
[TBL] [Abstract][Full Text] [Related]
8. Approaches to the construction of new candidate poliovirus type 3 vaccine strains.
Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD
Dev Biol Stand; 1993; 78():161-9; discussion 169-70. PubMed ID: 8388827
[TBL] [Abstract][Full Text] [Related]
9. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
10. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar.
Rakoto-Andrianarivelo M; Gumede N; Jegouic S; Balanant J; Andriamamonjy SN; Rabemanantsoa S; Birmingham M; Randriamanalina B; Nkolomoni L; Venter M; Schoub BD; Delpeyroux F; Reynes JM
J Infect Dis; 2008 May; 197(10):1427-35. PubMed ID: 18419577
[TBL] [Abstract][Full Text] [Related]
11. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.
Combiescu M; Guillot S; Persu A; Baicus A; Pitigoi D; Balanant J; Oprisan G; Crainic R; Delpeyroux F; Aubert-Combiescu A
Arch Virol; 2007; 152(4):727-38. PubMed ID: 17195957
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
Martín J; Minor PD
J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
[TBL] [Abstract][Full Text] [Related]
13. Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria.
Korsun N; Kojouharova M; Vladimirova N; Fiore L; Litvinenko I; Buttinelli G; Fiore S; Voynova-Georgieva V; Mladenova Z; Georgieva D
J Med Virol; 2009 Sep; 81(9):1661-7. PubMed ID: 19626606
[TBL] [Abstract][Full Text] [Related]
14. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
[TBL] [Abstract][Full Text] [Related]
15. [Problems of prevention and control of poliomyelitis in Poland].
Mazurowska-Magdzik W; Bucholc B; Janaszek-Seydlitz W; Szkoda T; Magdzik W
Przegl Epidemiol; 2010; 64(3):341-7. PubMed ID: 20976944
[TBL] [Abstract][Full Text] [Related]
16. Evolution and polymorphism of poliovirus genomes.
Crainic R; Kew O
Biologicals; 1993 Dec; 21(4):379-84. PubMed ID: 8024754
[TBL] [Abstract][Full Text] [Related]
17. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
[TBL] [Abstract][Full Text] [Related]
19. Infectious diseases. Polio outbreak raises questions about vaccine.
Greensfelder L
Science; 2000 Dec; 290(5498):1867-9. PubMed ID: 11187033
[No Abstract] [Full Text] [Related]
20. Recombinant vaccine-derived poliovirus in Madagascar.
Rousset D; Rakoto-Andrianarivelo M; Razafindratsimandresy R; Randriamanalina B; Guillot S; Balanant J; Mauclère P; Delpeyroux F
Emerg Infect Dis; 2003 Jul; 9(7):885-7. PubMed ID: 12899139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
